Gene therapy halts pulmonary hypertension progression in large animal pre-clinical studyApril 28, 2016
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai. The study was published online this week, and will appear in the May 3 issue of the Journal of the American College of Cardiology (JACC).
Pulmonary arterial hypertension (PAH) is a rare, rapidly progressing disease that occurs when blood pressure is too high in vessels leading from the heart to the lungs. There is currently no cure for PAH, and about 50 percent of people who are diagnosed will die from the disease within five years. The high pressure is caused by abnormal remodeling of the lung blood vessels that sometimes leads to failure of the right ventricle and premature death. Thickening and narrowing of pulmonary vessels is seen with all types of pulmonary hypertension and is triggered by abnormal calcium levels within the vascular cells. The sarcoplasmic reticulum calcium ATPase pump (SERCA2a) regulates intracellular calcium in vascular cells and prevents them from proliferating in the vessel wall.
"There is considerable need for new treatments that improve functional capacity, symptoms, and survival," said Dr. Hajjar. "This treatment with gene therapy offers a novel method of treating a deadly disease that disproportionately affects young adults and women," he said. Female patients make up about 72 percent of the total population of patients with PAH.
"The therapeutic potential of using gene therapy to treat pulmonary hypertension by delivery of aerosolized adeno-associated virus carrying SERCA2a to directly target vascular remodeling through the overexpression of the SERCA2a protein is very significant," said co-senior study author Jane A. Leopold, MD, of Brigham and Women's Hospital, Harvard Medical School. "In addition, as other novel targets are identified by deep phenotyping of patients with pulmonary hypertension in the National Institutes of Health/National, Heart, Lung, & Blood Institute-funded Pulmonary Vascular Disease Phenomics (PVDOMICS) study, they may be viable candidates for aerosolized gene transfer using adeno-associated viral vectors."
There were two primary objectives for this study, which was conducted by Mount Sinai and research teams from Brigham & Women's Hospital in Boston, MA, and Centro Nacional de Investigaciones Cardiovasculares Carlos III in Madrid, Spain. First, scientists wanted to learn if it is feasible to deliver a therapeutic gene called SERCA2a in aerosol form to damaged blood vessels of the lung using an engineered adeno-associated virus as a "vector." Second, they wanted to see if there was a sustained beneficial impact, and if the transferred genes effectively slowed or stopped the vascular changes in the airways that are the hallmark of PAH and other forms of pulmonary hypertension.
Previously, the novel aerosol inhalation technique used to deliver the SERCA2a gene in this study had proven effective in a rodent model. However, the current study is the first to explore this approach in a large animal--specifically, a Yorkshire swine model that closely resembles PH in humans.
In the study, 20 pigs were divided into two groups, half of which received the aerosolized viral vector carrying the SERCA2a gene and half a saline spray. Two months after the gene delivery, scientists performed tests to see if the new therapeutic genes were present and functioning in the vessels of the animals' lungs, and whether the transfer was producing the desired effects. When they examined the animals, they found that that heart and lung function had improved and abnormal cellular changes causing PH were reduced.
"I'm excited that there is a potential new treatment for patients with this deadly disease," Dr. Hajjar said. "By tailoring the gene therapy, it looks like we can halt the proliferation of smooth muscle cells in the blood vessels. This should help restore function and improve survival in human patients."
Dr. Hajjar said that additional animal studies focusing on long-term efficacy and safety are warranted before advancing this approach, known as airway gene delivery, to human clinical trials. That's because the current study involved a small number of animals, and they were assessed just eight weeks after gene delivery. Nevertheless, he said, airway gene delivery appears to modify fundamental pathophysiology, and therefore might offer therapeutic benefit to humans with a variety of pulmonary vascular diseases.
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services--from community-based facilities to tertiary and quaternary care.
The System includes approximately 6,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is ranked as one of the nation's top 10 hospitals in Geriatrics, Cardiology/Heart Surgery, and Gastroenterology, and is in the top 25 in five other specialties in the 2015-2016 "Best Hospitals" issue of U.S. News & World Report. Mount Sinai's Kravis Children's Hospital also is ranked in seven out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology, while Mount Sinai Beth Israel is ranked regionally.
For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
The Mount Sinai Hospital / Mount Sinai School of Medicine
Related Heart Failure Articles:
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Chronic inflammation after a heart attack can promote heart failure and death.
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Smokers without obvious signs of heart disease were more likely than nonsmokers and former smokers to have thickened heart walls and reduced heart pumping ability.
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death.
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of six-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.
Related Heart Failure Reading:
Heart Failure: A Companion to Braunwald's Heart Disease, 3e
by Douglas L. Mann MD (Author), G. Michael Felker MD MHS FACC FAHA (Author)
Lead editor of Braunwald’s Heart Disease, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring you the latest, definitive state-of-the art information on heart failure in this outstanding Braunwald’s companion volume. Heart Failure, 3rd Edition, keeps you current with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients’ lives and in your practice. Braunwald’s Heart Failure... View Details
Living Well with Heart Failure, the Misnamed, Misunderstood Condition
by Edward K. Kasper (Author), Mary Knudson (Author)
Heart failure―the expression alone is scary. The idea that the blood-pumping organ in our chest can struggle, stutter, or suddenly stop is deeply disconcerting. But for those who get the diagnosis, the future is not necessarily bleak. With the right treatments and a healthy lifestyle that includes exercise and good nutrition, many people with heart failure can improve their condition and live well.
Heart failure expert Edward K. Kasper, M.D., teams with journalist―and survivor―Mary Knudson to give readers an honest account of this misunderstood condition. The authors... View Details
Heart Failure Pocketcard Set
by M.D. Szady (Author), M.D. Bavry (Author)
by Richard Mabry (Author)
When her fiancé’s dangerous secrets turn her work upside down, a beautiful doctor must choose between her own safety and the man she loves—and thought she knew.
Dr. Carrie Markham’s heart was broken by the death of her husband two years ago. Now, just as her medical practice is taking off, her fresh engagement to paralegal Adam Davidson seems almost too good to be true . . . until a drive-by shooting leaves Carrie on the floor of his car with glass falling around her.
When he confesses that Adam isn’t his real name and that he fled the witness protection program,... View Details
Heart Failure Recovery: Complete Failure to Complete Recovery
by Ray Reynolds (Author)
”Our knowledge of human biology doubles every four years.” This makes it nearly impossible for physicians to stay current on the latest research in their own fields let alone in all of the others that directly effect their ability to properly treat their patients. In this new book by Bio Researcher Ray Reynolds you will learn... How heart muscle cells have the ability to stay alive by hibernating when deprived of oxygen. The four nutriants needed to revive them after the coranary artery blockage has been removed. How to utilize minimum effective doses of heart medications to regulate... View Details
Heart Failure: An Incredibly Easy! Miniguide
by Springhouse (Editor)
Witty explanations and amusing illustrations — along with authoritative advice — allow nurses and other health care professionals to quickly sharpen their skills the Incredibly Easy! way. Features an eight-page, color guide to pathophysiology. Contents include understanding heart failure, preventing heart failure, assessing patients with heart failure, treating patients with heart failure, heart failure complications, and teaching patients with heart failure. View Details
How I reversed congestive heart failure: How I Reversed Congestive Heart Failure
by Anthony Westbrooks Westbrooks (Author)
I’m not a medical physician nor do I have any extensive education on heart disease or congestive heart failure. I’m simply your everyday guy who found himself with a critical medical condition that if not treated correctly, could easily cost me my life. Congestive heart failure (CHF) is a very serious condition that shouldn’t be ignored. Honestly, I can say when I was first informed of my condition; I wasn’t’ concerned about who else was suffering from this condition or other people’s opinions. What was fresh in my mind was that my father died three months after being diagnosed... View Details
Congestive Heart Failure: Understanding and Surviving the Disease with 12 Simple Steps
by Star James (Author)
Some of the risk factors of heart disease cannot be control such as age, gender and family history, whereas others are things we can change such as smoking, poor diet, lack of physical activity, stress, depression and poor hygiene. According to WHO, 80% of heart disease cases can be attributed to behavioral risk factors (those that we can change). This Book will show you how to eliminate all those behavioral risk factors from your life and improve your heart health. Easy to implement, effective and side effect free, these Healthy habits will boost your energy levels and help you improve... View Details
Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management (HEART FAILURE: PATHOPHYSIOLOGY, MOLEC BIOL & CLIN MGT)
by Arnold M. Katz MD (Author), Marvin A. Konstam MD (Author)
This Second Edition of Dr. Katz's highly acclaimed text has been thoroughly revised to incorporate the latest advances in the study and treatment of heart failure. The book explains the pathophysiology, molecular mechanisms, clinical manifestations, and therapy of heart failure in an integrated, reader-friendly manner that is accessible to both clinicians and basic scientists. More than 100 illustrations, most created for this book by the authors, complement the text.
This edition has been completely reorganized. Chapters describe the hemodynamic basis for the clinical... View Details
Heart Failure: A Comprehensive Guide to Pathophysiology and Clinical Care
by Howard Eisen (Editor)
This comprehensively covers everything from pathophysiology to the evaluation of patients presenting with heart failure to medical management, device therapy, heart transplantation and mechanical circulatory support, and include relevant cardiac imaging studies such as echocardiograms and magnetic resonance imaging studies which could be seen in their entirety as well as pathology slides, hemodynamic tracings and videos of cardiac surgery such as heart transplants and ventricular assist device implantation. Finally, the book would have videos of patients with heart failure, heart transplants... View Details